ProKidney Corp. (PROK) — Financial statements
Income statement, balance sheet, and cash flow for ProKidney Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.89↑1075.0% | 0.08 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 6 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -5↓6453.9% | 0.08 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 114↓10.6% | 128↑19.6% | 107↑30.0% | 82↑77.4% | 46 | |
| General & Administrative Expenses | 52↓7.7% | 56↑25.1% | 45↓36.8% | 71↑701.1% | 9 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 52↓7.7% | 56↑25.1% | 45↓36.8% | 71↑701.1% | 9 | |
| Other Expenses | -6 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 160↓13.0% | 184↑21.3% | 152↓1.0% | 153↑177.6% | 55 | |
| Total Costs & Expenses | 166↓9.9% | 184↑21.3% | 152↓1.0% | 153↑177.6% | 55 | |
| Operating Results | ||||||
| Operating Income | -165↑10.2% | -184↓21.2% | -152↑1.0% | -153↓177.6% | -55 | |
| Depreciation & Amortization | 6↑5.3% | 5↑41.0% | 4↑26.9% | 3↑53.0% | 2 | |
| EBITDA | -159↓0.3% | -158↓26.2% | -126↑12.8% | -144↓171.0% | -53 | |
| EBIT | -165↓0.5% | -164↓26.6% | -129↑12.0% | -147↓166.8% | -55 | |
| Interest & Other Income | ||||||
| Net Interest Income | 14↓30.1% | 20↓10.5% | 22↑282.6% | 6↑288300.0% | 0.00 | |
| Interest Income | 14↓30.1% | 20↓10.6% | 22↑269.1% | 6↑299050.0% | 0.00 | |
| Interest Expense | 0.00↓55.6% | 0.01↓25.0% | 0.01↓94.4% | 0.22 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -20↑10.6% | -22↓269.1% | -6↓299050.0% | -0.00 | |
| Other Income / Expenses | 13↓31.7% | 20↓10.5% | 22↑282.6% | 6↑288300.0% | 0.00 | |
| Income Before Tax | -151↑7.8% | -164↓26.6% | -129↑12.1% | -147↓167.2% | -55 | |
| Income Tax Expense | 0.41↑169.2% | -0.60↓110.0% | 6↑569.2% | 0.90↑2257.9% | 0.04 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -152↑7.2% | -163↓20.6% | -135↑8.6% | -148↓168.6% | -55 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -69↓12.7% | -61↓72.5% | -35↑67.2% | -108↓95.9% | -55 | |
| Bottom-Line Net Income | -69↓12.7% | -61↓72.5% | -35↑67.2% | -108↓95.9% | -55 | |
| EPS (Basic) | -0.52↑16.1% | -0.62↓8.8% | -0.57↑67.6% | -1.76↓1.7% | -1.73 | |
| EPS (Diluted) | -0.52↑16.1% | -0.62↓8.8% | -0.57↑67.6% | -1.76↓1.7% | -1.73 | |
| Weighted Average Shares | 134↑36.8% | 98↑58.7% | 62↑0.3% | 62↑93.0% | 32 | |
| Weighted Average Diluted Shares | 134↑36.8% | 98↑58.7% | 62↑0.3% | 62↑93.0% | 32 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.